These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2783952)

  • 41. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the number and distribution of Langerhans cells in the hydantoin hyperplasic gingiva as compared with the clinically normal one.
    Ibáñez P; Sagredo E; Pino A
    Histol Histopathol; 1990 Oct; 5(4):433-8. PubMed ID: 1724931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).
    McCartan BE; Lamey PJ
    J Oral Pathol Med; 1997 Apr; 26(4):176-80. PubMed ID: 9176792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.
    van Voorst Vader PC; de Jong MC; Blanken R; Kallenberg CG; Vermey A; Scheres JM
    Arch Dermatol Res; 1987; 279(6):366-73. PubMed ID: 3499869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the gingival status by quantification of the T6 (CD1a) and HLA-DR antigens].
    Sagredo E; Pino A; Ibañez P
    J Biol Buccale; 1990 Sep; 18(3):163-8. PubMed ID: 1701432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of immature primary Langerhans cells from human epidermal skin.
    de Jong MA; de Witte L; Geijtenbeek TB
    Methods Mol Biol; 2010; 595():55-65. PubMed ID: 19941105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
    Rhodes J; Tite J
    J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sections.
    Haid B; Reider D; Nägele F; Spinoit AF; Pechriggl E; Romani N; Fritsch H; Oswald J
    BMC Urol; 2019 Nov; 19(1):114. PubMed ID: 31718599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells.
    Verrier AC; Schmitt D; Staquet MJ
    Int Arch Allergy Immunol; 1999 Sep; 120(1):56-62. PubMed ID: 10529589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sialyl LewisX expression on human Langerhans cells.
    Tabata N; Aiba S; Nakagawa S; Ohtani H; Tagami H
    J Invest Dermatol; 1993 Aug; 101(2):175-9. PubMed ID: 7688403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis.
    Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
    Scand J Immunol; 1985 Nov; 22(5):471-7. PubMed ID: 2934800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UVB and UVC, but not UVA, potently induce the appearance of T6- DR+ antigen-presenting cells in human epidermis.
    Baadsgaard O; Wulf HC; Wantzin GL; Cooper KD
    J Invest Dermatol; 1987 Jul; 89(1):113-8. PubMed ID: 3598201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
    Walsh LJ; Seymour GJ; Powell RN
    J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnesium ions inhibit the antigen-presenting function of human epidermal Langerhans cells in vivo and in vitro. Involvement of ATPase, HLA-DR, B7 molecules, and cytokines.
    Schempp CM; Dittmar HC; Hummler D; Simon-Haarhaus B; Schulte-Mönting J; Schöpf E; Simon JC
    J Invest Dermatol; 2000 Oct; 115(4):680-6. PubMed ID: 10998143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo retinoic acid modulates expression of the class II major histocompatibility complex and function of antigen-presenting macrophages and keratinocytes in ultraviolet-exposed human skin.
    Meunier L; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1996 May; 106(5):1042-6. PubMed ID: 8618036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A combined regimen of etretinate and UVB modulate T6+ and HLA-DR+ epidermal cells.
    Kim YH; Kim CW; Houh W
    J Korean Med Sci; 1987 Jun; 2(2):89-96. PubMed ID: 3271057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function.
    Péguet-Navarro J; Dalbiez-Gauthier C; Dezutter-Dambuyant C; Schmitt D
    Eur J Immunol; 1993 Feb; 23(2):376-82. PubMed ID: 8436173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solar-simulating irradiation of the skin of human subjects in vivo produces Langerhans cell responses distinct from irradiation ex vivo and in vitro.
    Laihia JK; Jansen CT
    Exp Dermatol; 2000 Aug; 9(4):240-7. PubMed ID: 10949544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.